Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - ENTEST GROUP, INC. | entb022817form10q.htm |
| EX-32.2 - EXHIBIT 32_2 - ENTEST GROUP, INC. | ex32_2.htm |
| EX-32.1 - EXHIBIT 32_1 - ENTEST GROUP, INC. | ex32_1.htm |
| EX-31.2 - EXHIBIT 31_2 - ENTEST GROUP, INC. | ex31_2.htm |
| EX-31.1 - EXHIBIT 31_1 - ENTEST GROUP, INC. | ex31_1.htm |
| EX-10.1 - EXHIBIT 10_1 - ENTEST GROUP, INC. | ex10_1.htm |
Exhibit 10.2
Exhibit 10.2
ENTEST BIOMEDICAL,INC AND THOMAS E. ICHIM AGREEMENT
Entest Biomedical, Inc. agrees to purchase Regen BioPharma Inc.’s certificate #RA 576 for 3,500,000 series A preferred shares from Thomas E. Ichim ( owner) for the price of $5,000 cash and 500,000 Entest Biomedical, Inc. series B preferred shares.
Thomas E. Ichim acknowledges that his Regen Biophrama series A preferred shares are free of any encumbrances and able to be transferred to Entest Biomedical, Inc.
Signed in Agreement February 28, 2017
| /s/ David Koos | ||
| By: David Koos, CEO | ||
| ENTEST BIOMEDICAL, Inc. | ||
| /s/ Thomas E. Ichim | ||
| By: Thomas E. Ichim | ||
| Seller of Regen Biopharma | ||
| Series A Shares |